Welcome to our dedicated page for Crescent Capital Bdc news (Ticker: CCAP), a resource for investors and traders seeking the latest updates and insights on Crescent Capital Bdc stock.
Crescent Capital BDC Inc (NASDAQ: CCAP) delivers essential financing solutions to U.S. middle-market companies through structured debt and strategic equity investments. This news hub provides investors and financial professionals with centralized access to the company's latest developments, regulatory filings, and market-moving announcements.
Track critical updates including quarterly results, portfolio company activity, capital structure changes, and leadership developments. Our curated news feed combines press releases with verified financial reporting, offering transparent insights into CCAP's disciplined investment approach and middle-market positioning.
Discover timely information on credit facility expansions, dividend declarations, and strategic portfolio adjustments. All content undergoes rigorous verification to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of CCAP's evolving role in middle-market finance. Combine our news updates with SEC filings and earnings transcripts for comprehensive analysis of the company's risk-managed growth strategy.
Crescent Capital BDC will release its financial results for Q4 and fiscal year ended December 31, 2021, on February 23, 2022, after market close. A conference call will be held the following day, February 24, 2022, at 12:00 p.m. ET, where management will discuss the results. Interested parties can join via the company's website or by phone. Crescent BDC, a business development company, aims to provide capital solutions to middle-market companies, maximizing returns through current income and capital appreciation.
Crescent Capital BDC, Inc. (CCAP) has priced an underwritten offering of 2,500,000 shares of its common stock at $21.33 per share, aiming to raise approximately $53.3 million in net proceeds. An option to purchase an additional 375,000 shares is granted to underwriters. The offering follows the Company's shelf-registration statement approved by the SEC and is expected to close on November 18, 2021. Proceeds will be used for general corporate purposes, including debt repayment and investments in portfolio companies.
Crescent Capital BDC, Inc. (NASDAQ: CCAP) announced a primary offering of 2,500,000 shares of common stock, with an option for underwriters to purchase an additional 375,000 shares. The offering is registered with the SEC, and the proceeds will be utilized for general corporate purposes, including debt repayment and investments. Crescent's investment adviser will pay underwriters a supplemental payment to cover the difference between the actual offering price and net proceeds. The offering will be managed by multiple financial institutions, including BofA Securities and Wells Fargo.
Crescent Capital BDC (CCAP) reported a net investment income of $12.7 million ($0.45 per share) for Q3 2021, up from $11 million in Q2 2021. Adjusted net investment income was $13.5 million ($0.48 per share). The net asset value per share rose to $21.16 compared to $20.98 in the previous quarter. The firm declared cash dividends totaling $0.41 per share for regular dividends and additional special dividends worth $0.05 each. Investments at fair value increased to $1,138.6 million, with a portfolio comprising 132 companies.
Crescent Capital BDC (NASDAQ: CCAP) will release its third-quarter financial results for the period ending September 30, 2021, on November 10, 2021, after market close. A conference call to discuss these results is scheduled for November 11, 2021, at 12:00 p.m. Eastern Time, accessible via their investor relations website. Crescent BDC focuses on maximizing stockholder returns by providing capital solutions to middle-market companies. The firm is managed by Crescent Cap Advisors, a subsidiary of Crescent Capital Group, which manages over $35 billion in assets.
Crescent Capital BDC, Inc. (CCAP) reported net investment income of $11.0 million ($0.39 per share) for Q2 2021, with adjusted net investment income at $14.8 million ($0.53 per share). The net asset value per share rose to $20.98 from $20.24 in Q1 2021. A cash dividend of $0.41 per share was declared for Q3 2021, payable on October 15, 2021. Total investments increased to $1,095.0 million. Investment income rose to $23.8 million from $20.6 million in Q1 2021, driven by portfolio expansion, while expenses climbed to $12.8 million due to capital gains-based fees.
Crescent Capital BDC, Inc. (NASDAQ: CCAP) will release its financial results for Q2 2021 after market close on August 11, 2021. A conference call to discuss these results will be held on August 12, 2021, at 12:00 p.m. ET. Interested parties can access the call via the company's Investor Relations webpage or by dialing the provided numbers. Crescent BDC aims to maximize shareholder returns through investments in middle-market companies with strong growth potential.
Crescent Capital BDC (CCAP) reported a net investment income of $11.4 million ($0.41 per share) for Q1 2021, alongside adjusted net investment income of $13.0 million ($0.46 per share). The net asset value per share increased to $20.24 from $19.88 in Q4 2020. A cash dividend of $0.41 per share was declared for Q2 2021, payable on July 15. The company completed a $135 million offering of senior unsecured notes and reduced its debt, achieving a debt to equity ratio of 0.86x.
Crescent Capital BDC (NASDAQ: CCAP) will announce its financial results for Q1 2021 on May 12, 2021, post-market close. A conference call is scheduled for May 13, 2021, at 12:00 p.m. ET, where management will discuss the results. Interested parties can access the call via a dedicated phone line or through the Investor Relations section of Crescent BDC's website. Crescent BDC focuses on maximizing stockholder returns by providing capital solutions to middle-market companies with robust growth potential.
Crescent Capital BDC, Inc. (NASDAQ: CCAP) reported net investment income of $49.9 million for the year ended December 31, 2020, equating to $1.80 per share. The net increase in net assets resulting from operations was $54.7 million, or $1.98 per share. As of December 31, 2020, the net asset value per share stood at $19.88, up from $19.07 at September 30, 2020. The company declared a regular cash dividend of $0.41 per share for Q1 2021, payable on April 15, 2021. Crescent successfully completed a $135 million private offering of senior unsecured notes.